Browsing Topic

ASX COV

1 post

Cleo Diagnostics reports its ovarian cancer blood tests superior to ultrasound

Nine moths after listing on the ASX, Cleo Diagnostics (ASX:COV) has made its first major biotech breakthrough.
  • 2 mins
  • 29 May 2024 10:36 (AEDT)